Simavita Limited Annual Report 2020

Annual Report 2020 21 Consolidated Notes June 30, 2020 $ June 30, 2019 $ Revenue 4 43,469 184,576 Cost of sales (19,997) (86,969) Gross profit 23,472 97,607 Other income 5 1,009,231 720,514 Expenses Finance costs (518,448) (224,663) General and administration (2,292,565) (1,870,821) Occupancy costs (30,013) (143,219) Research and development (1,671,041) (1,109,442) Sales, marketing and distribution (563,038) (1,347,492) Share-based payments expense (24,000) (56,700) Loss before income tax (4,066,402) (3,934,216) Income tax 8 – – Loss for the year (4,066,402) (3,934,216) Other comprehensive income Items that may be subsequently reclassified to profit/ (loss) Translation of foreign operation (277) 1,861 Total comprehensive loss for the year (4,066,679) (3,932,355) Cents Cents Earnings per share for loss from continuing operations attributable to the ordinary equity holders of the Group: Basic loss per common share 7 (0.01) (0.01) Diluted loss per common share 7 (0.01) (0.01) Earnings per share for loss attributable to the ordinary equity holders of the Group: Basic loss per common share 7 (0.01) (0.01) Diluted loss per common share 7 (0.01) (0.01) The accompanying notes form an integral part of these consolidated financial statements Consolidated Statement of Comprehensive Loss for the year ended June 30, 2020

RkJQdWJsaXNoZXIy MjE2NDg3